Chemotherapeutic Agents Can Activate the cGAS‐STING Pathway, and cGAS Inhibition Enhances the Tumor‐Killing Effect in PTCL. This evidence concerns the gene CGAS and mature T-cell and NK-cell non-Hodgkin lymphoma.